{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_immune_response",
          "type": "Target",
          "label": "Immune Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_psoriasis_pathway",
          "type": "Pathway",
          "label": "Psoriasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pheno_skin_inflammation",
          "type": "Phenotype",
          "label": "Skin Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pheno_systemic_symptoms",
          "type": "Phenotype",
          "label": "Systemic Symptoms",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Thalidomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_acitretin",
          "target": "n_target_immune_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于调节免疫反应"
        },
        {
          "source": "n_apremilast",
          "target": "n_target_immune_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于调节免疫反应"
        },
        {
          "source": "n_etanercept",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_infliximab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_secukinumab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_cyclosporine",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_methotrexate",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_adalimumab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_interleukin_17_inhibitors",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_topical_corticosteroids",
          "target": "n_target_psoriasis_pathway",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知用于调节皮肤反应"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_thalidomide",
          "target": "n_target_immune_response",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已知用于调节免疫反应"
        },
        {
          "source": "n_target_immune_response",
          "target": "n_target_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "调控通路关联"
        },
        {
          "source": "n_target_psoriasis_pathway",
          "target": "n_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "病理通路关联"
        },
        {
          "source": "n_target_immune_response",
          "target": "n_pheno_skin_inflammation",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "免疫反应引发皮肤炎症"
        },
        {
          "source": "n_target_immune_response",
          "target": "n_pheno_systemic_symptoms",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫反应引发系统性症状"
        }
      ],
      "round_index": 1
    },
    "history": {
      "round": 1,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.81,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Acitretin 通过调节免疫反应同时影响皮肤炎症与损伤通路"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.78,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.02
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Apremilast 通过调节免疫反应来减轻皮肤和系统症状"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.84,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.7,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.02
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Etanercept 通过抑制免疫反应有效控制该病"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.84,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.02
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Infliximab 通过抑制免疫反应有效用于治疗"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.75,
          "components": {
            "mechanism_fit": 0.82,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.02
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Secukinumab 通过抑制免疫通路来减轻病症"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.72,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.45,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.65,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Cyclosporine 通过抑制免疫系统响应缓解病症"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.7,
          "components": {
            "mechanism_fit": 0.73,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.65,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Methotrexate 通过抑制免疫反应缓解病症"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.7,
          "components": {
            "mechanism_fit": 0.73,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.65,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Adalimumab 通过抑制免疫应答来缓解症状"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.72,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.65,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 0.78,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Interleukin-17 inhibitors 通过抑制免疫通路减轻病症"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.68,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.6,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Topical corticosteroids 通过调节皮肤应答减轻炎症"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.69,
          "components": {
            "mechanism_fit": 0.72,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.6,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Ustekinumab 通过抑制免疫反应缓解病症"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.66,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.55,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Thalidomide 通过调节免疫反应可能有助于治疗"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_acitretin",
            "via": [
              "n_target_immune_response"
            ],
            "to": "n_generalised_pustular_psoriasis",
            "success_criteria": "形成不相交路径以增强支持证据",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "讨论不同药物在防治广泛性脓疱型银屑病中的作用机制差异"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_apremilast",
            "via": [
              "n_target_immune_response"
            ],
            "to": "n_generalised_pustular_psoriasis",
            "success_criteria": "形成不相交路径以增强支持证据",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "探讨apremilast和其他药物的作用机制"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_etanercept",
            "via": [
              "n_target_immune_response"
            ],
            "to": "n_generalised_pustular_psoriasis",
            "success_criteria": "形成不相交路径以增强支持证据",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "研究etanercept在治疗广泛性脓疱型银屑病中的机制"
        ]
      }
    ],
    "seed_request": {
      "should_regenerate": true,
      "reason": "现有药物假设在多条不相交路径欠缺，需增强机制连通性以支持泛用性主张。",
      "n": 4
    }
  }
}